Stocktoria

Absci Corp ABSI

Nasdaq · stock · Services-Commercial Physical & Biological Research · website · IPO 2021-07-22

Absci Corp statistics & valuation

Market cap$1.7B
P / B9.0×
Net margin-4113.7%
Return on equity-60.8%
FCF margin-3358.3%
Return on capital-62.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-300.30% -2111.30% -1825.40% -1933.60% -2274.10% -4113.70% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-278.30% -1573.40% -1857.50% -2020.20% -2401.60% -4297.00% 202020212022202320242025
Return on equity (%)
-27.60% -38.20% -62.80% -57.60% -60.80% 202020212022202320242025
Shares outstanding
17.9M 92.6M 92.4M 93.1M 115.4M 136.8M 202020212022202320242025
Net debt ($)
-$249.0M -$49.0M -$64.4M -$37.2M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-16.20% -23.70% -32.70% -50.90% -48.30% -53.30% 202020212022202320242025
Free cash flow margin (%)
-275.10% -2062.80% -1696.80% -1145.40% -1605.80% -3358.30% 202020212022202320242025
Debt / equity (×)
0.01× 0.04× 0.04× 0.02× 202020212022202320242025
EPS ($)
-$3.19 -$2.08 -$1.15 -$1.20 -$0.94 -$0.84 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-4297.0%-2401.6%-2020.2%-1857.5%-1573.4%-278.3%
Net margin-4113.7%-2274.1%-1933.6%-1825.4%-2111.3%-300.3%
FCF margin-3358.3%-1605.8%-1145.4%-1696.8%-2062.8%-275.1%
Return on assets-53.3%-48.3%-50.9%-32.7%-23.7%-16.2%
Return on equity-60.8%-57.6%-62.8%-38.2%-27.6%16.0%
Debt / equity—0.02×0.04×0.04×0.01×—
Current ratio6.574.674.086.178.077.25

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.